Bio-Techne signs a license agreement with Luminary
Investor Relations for NASDAQ and NYSE Public Companies Call OTC Tip Reporter 800-850-9305
Bio-Techne signs a license agreement with Luminary Therapeutics
OTC Tip Reporter is currently taking on new clients that are looking for more coverage for their companies that are trading on the NASDAQ and NYSE. You may visit us online at https://www.otctipreporter.com/ to read our disclaimer and about our media packages and marketing services to NASDAQ and NYSE trading companies. Get in touch with us by calling 1-800-850-9305.
-
Professional Investor Relations Packages Offered by OTC Tip Reporter Assist NASDAQ and NYSE Companies Increase Visibility to Shareholders